Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

All articles

DNA-Encoded Libraries and AI for Compound Identification

An expert interview on the use of DNA-encoded libraries for connection detection.

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Article

From bottleneck to breakthrough: Why AI is crucial for progress in healthcare and pharma

Rising costs, a shortage of specialists and a flood of data are pushing the healthcare system and the pharmaceutical industry to their limits. Why artificial intelligence is now the key to taking care, research and development to a new level.

Article

How do you make 30 years of data accessible?

In conversation with Jonas Münch, who developed a RAG chatbot at Bayer that combines 30 years of internal data and clinical results in one place.

Article

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.